Late and very late stent thrombosis after polymer-based sirolimus- or paclitaxel-eluting stent implantation in real-world clinical practice.
- Author:
Wei-Feng SHEN
- Publication Type:Editorial
- MeSH:
Aspirin;
therapeutic use;
Coronary Disease;
therapy;
Coronary Thrombosis;
chemically induced;
epidemiology;
mortality;
Drug-Eluting Stents;
adverse effects;
Humans;
Paclitaxel;
therapeutic use;
Platelet Aggregation Inhibitors;
therapeutic use;
Polymers;
chemistry;
Sirolimus;
therapeutic use;
Ticlopidine;
analogs & derivatives;
therapeutic use
- From:
Chinese Medical Journal
2010;123(7):773-775
- CountryChina
- Language:English
